Cullinan Associates’s Teva Pharmaceuticals TEVA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2014 Q3	–	Sell	-38,200	Closed	-$1.5M	–	96
2014 Q2	$1.5M	Buy	+38,200	New	+$1.5M	0.24%	56
2013 Q3	–	Sell	-46,744	Closed	-$1.83M	–	90
2013 Q2	$1.83M	Buy	+46,744	New	+$1.83M	0.25%	55